205 related articles for article (PubMed ID: 28607011)
21. Economic evaluation of caspofungin vs liposomal amphotericin B for empirical therapy of suspected systemic fungal infection in the German hospital setting.
Kaskel P; Tuschy S; Wagner A; Bannert C; Cornely OA; Glasmacher A; Lipp HP; Ullmann AJ
Ann Hematol; 2008 Apr; 87(4):311-9. PubMed ID: 17929018
[TBL] [Abstract][Full Text] [Related]
22. Safety and tolerability of high-dose weekly liposomal amphotericin B antifungal prophylaxis.
Hand EO; Ramanathan MR
Pediatr Infect Dis J; 2014 Aug; 33(8):835-6. PubMed ID: 25222303
[TBL] [Abstract][Full Text] [Related]
23. Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis.
Safdar A; Ma J; Saliba F; Dupont B; Wingard JR; Hachem RY; Mattiuzzi GN; Chandrasekar PH; Kontoyiannis DP; Rolston KV; Walsh TJ; Champlin RE; Raad II
Medicine (Baltimore); 2010 Jul; 89(4):236-244. PubMed ID: 20616663
[TBL] [Abstract][Full Text] [Related]
24. [Safety of liposomal amphotericin B in patients with high risk of nephrotoxicity].
González E; Rada MA; Lumbreras C; Ramos JT; Aguado JM
Enferm Infecc Microbiol Clin; 2000 Apr; 18(4):162-4. PubMed ID: 10932392
[TBL] [Abstract][Full Text] [Related]
25. Association between potassium supplementation and the occurrence of acute kidney injury in patients with hypokalemia administered liposomal amphotericin B: a nationwide observational study.
Ota Y; Obata Y; Takazono T; Tashiro M; Wakamura T; Takahashi A; Shiozawa Y; Miyazaki T; Nishino T; Izumikawa K
BMC Nephrol; 2021 Jun; 22(1):240. PubMed ID: 34193064
[TBL] [Abstract][Full Text] [Related]
26. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
Walsh TJ; Teppler H; Donowitz GR; Maertens JA; Baden LR; Dmoszynska A; Cornely OA; Bourque MR; Lupinacci RJ; Sable CA; dePauw BE
N Engl J Med; 2004 Sep; 351(14):1391-402. PubMed ID: 15459300
[TBL] [Abstract][Full Text] [Related]
27. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
[TBL] [Abstract][Full Text] [Related]
28. [Retrospective investigation on the cases treated with liposomal amphotericin B].
Yamagishi Y; Mikamo H
Jpn J Antibiot; 2010 Oct; 63(5):347-64. PubMed ID: 21268407
[TBL] [Abstract][Full Text] [Related]
29. continuous versus conventional infusion of amphotericin B deoxycholate: a meta-analysis.
Falagas ME; Karageorgopoulos DE; Tansarli GS
PLoS One; 2013; 8(10):e77075. PubMed ID: 24204739
[TBL] [Abstract][Full Text] [Related]
30. Role of urine neutrophil gelatinase-associated lipocalin in the early diagnosis of amphotericin B-induced acute kidney injury.
Rocha PN; Macedo MN; Kobayashi CD; Moreno L; Guimarães LH; Machado PR; Badaró R; Carvalho EM; Glesby MJ
Antimicrob Agents Chemother; 2015 Nov; 59(11):6913-21. PubMed ID: 26303800
[TBL] [Abstract][Full Text] [Related]
31. Incidence of acute kidney injury in dogs with systemic mycotic infections treated with amphotericin B (1996-2020).
Chan JC; Dear J; Palm C; Reagan K
J Vet Intern Med; 2023; 37(3):1030-1037. PubMed ID: 37148178
[TBL] [Abstract][Full Text] [Related]
32. Pharmacoeconomic analysis of amphotericin B lipid complex versus liposomal amphotericin B in the treatment of fungal infections.
Kuti JL; Kotapati S; Williams P; Capitano B; Nightingale CH; Nicolau DP
Pharmacoeconomics; 2004; 22(5):301-10. PubMed ID: 15061680
[TBL] [Abstract][Full Text] [Related]
33. Burden of acute kidney injury in HIV patients under deoxycholate amphotericin B therapy for cryptococcal meningitis and cost-minimization analysis of amphotericin B lipid complex.
Tuon FF; Florencio KL; Rocha JL
Med Mycol; 2019 Apr; 57(3):265-269. PubMed ID: 29762761
[TBL] [Abstract][Full Text] [Related]
34. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
Walsh TJ; Pappas P; Winston DJ; Lazarus HM; Petersen F; Raffalli J; Yanovich S; Stiff P; Greenberg R; Donowitz G; Schuster M; Reboli A; Wingard J; Arndt C; Reinhardt J; Hadley S; Finberg R; Laverdière M; Perfect J; Garber G; Fioritoni G; Anaissie E; Lee J;
N Engl J Med; 2002 Jan; 346(4):225-34. PubMed ID: 11807146
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of liposomal amphotericin B for deep mycosis in patients with connective tissue disease.
Kotani T; Takeuchi T; Makino S; Hata K; Yoshida S; Nagai K; Wakura D; Isoda K; Hanafusa T
J Infect Chemother; 2013 Aug; 19(4):691-7. PubMed ID: 23325065
[TBL] [Abstract][Full Text] [Related]
36. Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study.
Riedel A; Choe L; Inciardi J; Yuen C; Martin T; Guglielmo BJ
BMC Infect Dis; 2007 Jul; 7():70. PubMed ID: 17605773
[TBL] [Abstract][Full Text] [Related]
37. A multicenter phase 2 study of empirical low-dose liposomal amphotericin B in patients with refractory febrile neutropenia.
Miyao K; Sawa M; Kurata M; Suzuki R; Sakemura R; Sakai T; Kato T; Sahashi S; Tsushita N; Ozawa Y; Tsuzuki M; Kohno A; Adachi T; Watanabe K; Ohbayashi K; Inagaki Y; Atsuta Y; Emi N
Int J Hematol; 2017 Jan; 105(1):79-86. PubMed ID: 27696283
[TBL] [Abstract][Full Text] [Related]
38. Must we really fear toxicity of conventional amphotericin B in oncological patients?
Mayer J; Doubek M; Vorlìcek J
Support Care Cancer; 1999 Jan; 7(1):51-5. PubMed ID: 9926976
[TBL] [Abstract][Full Text] [Related]
39. Safety analysis of liposomal amphotericin B in adult patients: anaemia, thrombocytopenia, nephrotoxicity, hepatotoxicity and hypokalaemia.
Shigemi A; Matsumoto K; Ikawa K; Yaji K; Shimodozono Y; Morikawa N; Takeda Y; Yamada K
Int J Antimicrob Agents; 2011 Nov; 38(5):417-20. PubMed ID: 21885259
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of treatment with liposomal amphotericin B in elderly patients at least 65 years old with hematological diseases.
Ueda S; Miyamoto S; Kaida K; Chizuka A; Kojima R; Takano J; Ogasawara T; Miyamoto K; Miyakoshi S; Kanda Y
J Infect Chemother; 2016 May; 22(5):287-91. PubMed ID: 26908230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
